The major theme of research in this group is the study of inflammatory mediators in the pathogenesis of lung diseases including asthma, chronic obstructuve pulmonary disease (COPD) and sarcoidosis. Our projects investigate mechanisms of development of disease, clinically useful markers of inflammation and novel approaches to intervention. Translational research is a particular focus of the group, notably with respect to breath analysis of oxidative stress and other markers of disease activity, especially in asthma, but also COPD and lung cancer. The investigators provide complementary expertise, facilitating both pre-clinical and clinical investigation.
Specific projects include:
Other potential projects:
Professor Paul S. Foster, University of Newcastle & Hunter Medical Research Institute
The group is currently supported by funding from the Sydney Partnership for Health, Education, Research & Enterprise (SPHERE).